Application of endoscopic ultrasonography in the diagnosis of early esophageal cancer

Abstract

Zheng Zhen, Zhu Zhaofeng. Application of endoscopic ultrasonography in the diagnosis of early esophageal cancer[J]. Journal of International Oncology, 2021, 48(3): 176-179.

References36

[1]	Ripley RT, Sarkaria IS, Grosser R, et al. Pretreatment dysphagia in esophageal cancer patients may eliminate the need for staging by endoscopic ultrasonography[J]. Ann Thorac Surg, 2016,101(1):226-230. DOI: 10.1016/j.athoracsur.2015.06.062. doi:10.1016/j.athoracsur.2015.06.062pmid:26603024
[2]	Jung HK, Tae CH, Lee HA, et al. Treatment pattern and overall survival in esophageal cancer during a 13-year period: a nationwide cohort study of 6 354 Korean patients[J]. PLoS One, 2020,15(4):e0231456. DOI: 10.1371/journal.pone.0231456. doi:10.1371/journal.pone.0231456pmid:32275699
[3]	Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016,66(2):115-132. DOI: 10.3322/caac.21338. doi:10.3322/caac.21338pmid:26808342
[4]	Lin Y, Totsuka Y, Shan B, et al. Esophageal cancer in high-risk areas of China: research progress and challenges[J]. Ann Epidemiol, 2017,27(3):215-221. DOI: 10.1016/j.annepidem.2016.11.004. doi:10.1016/j.annepidem.2016.11.004pmid:28007352
[5]	Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma[J]. Gastroenterology, 2018,154(2):360-373. DOI: 10.1053/j.gastro.2017.08.023. doi:10.1053/j.gastro.2017.08.023pmid:28823862
[6]	Zhu ZJ, Qi Z, Zhang J, et al. Untargeted metabolomics analysis of esophageal squamous cell carcinoma discovers dysregulated metabolic pathways and potential diagnostic biomarkers[J]. J Cancer, 2020,11(13):3944-3954. DOI: 10.7150/jca.41733. doi:10.7150/jca.41733pmid:32328198
[7]	许宗渠, 刘锦源, 周悦, 等. 超声内镜对食管癌术前TN分期诊断的准确性及其影响因素[J]. 中国临床研究, 2018,31(4):455-458. DOI: 10.13429/j.cnki.cjcr.2018.04.006.
[8]	Yang J, Luo GY, Liang RB, et al. Efficacy of endoscopic ultrasono-graphy for determining clinical T category for esophageal squamous cell carcinoma: data from 1 434 surgical cases[J]. Ann Surg Oncol, 2018,25(7):2075-2082. DOI: 10.1245/s10434-018-6406-9. doi:10.1245/s10434-018-6406-9pmid:29667114
[9]	刘春丽, 卞晓林, 王焱, 等. 内镜超声对食管癌术前分期的诊断价值分析[J]. 中国实用医药, 2016,11(26):65-66. DOI: 10.14163/j.cnki.11-5547/r.2016.26.036.
[10]	Hagens ERC, van Berge Henegouwen MI, van Sandick JW, et al. Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study[J]. BMC Cancer, 2019,19(1):662. DOI: 10.1186/s12885-019-5761-7. doi:10.1186/s12885-019-5761-7pmid:31272485
[11]	刘剑芳, 邵华飞, 屈东, 等. 食管癌转移淋巴结多层螺旋CT诊断标准探讨[J]. 癌症进展, 2016,14(1):56-58. DOI: 10.11877/j.issn.1672-1535.2016.14.01.16.
[12]	Ajani JA, D'Amico TA, Almhanna K, et al. Esophageal and esophagogastric junction cancers, version1. 2015[J]. J Natl Compr Canc Netw, 2015,13(2):194-227. DOI: 10.6004/jnccn.2015.0028.
[13]	刘晓妮, 贺利霞, 蒋洁. EUS联合PET-CT检查对食管癌术前T、N分期诊断的临床价值[J]. 中国CT与MRI杂志, 2018,16(12):78-80. DOI: 10.3969/j.issn.1672-5131.2018.12.025.
[14]	马跃峰, 邢鑫, 孔冉冉, 等. 食管癌术前超声内镜T、N分期与术后病理T、N分期的比较[J]. 现代肿瘤医学, 2018,26(21):3404-3407. DOI: 10.3969/j.issn.1672-4992.2018.21.013.
[15]	Ebi M, Shimura T, Yamada T, et al. Multicenter, prospective trial of white-light imaging alone versus white-light imaging followed by magnifying endoscopy with narrow-band imaging for the real-time imaging and diagnosis of invasion depth in superficial esophageal squamous cell carcinoma[J]. Gastrointest Endosc, 2015,81(6):1355-1361. DOI: 10.1016/j.gie.2014.11.015. doi:10.1016/j.gie.2014.11.015pmid:25683023
[16]	高亚东, 屈亚威, 刘海峰. 放大内镜与超声内镜对早期食管癌浸润深度诊断价值的Meta分析[J]. 重庆医学, 2019,48(1):98-101, 105. DOI: 10.3969/j.issn.1671-8348.2019.01.025.
[17]	杨惠珍, 张正行. 放大内镜与超声内镜对早期食管癌浸润深度的诊断价值[J]. 临床医学, 2020,40(5):34-36. DOI: 10.19528/j.issn.1003-3548.2020.05.013.
[18]	Shibahara T, Yamamoto N, Yakushiji T, et al, Narrow-band imaging system with magnifying endoscopy for early oral cancer[J]. Bull Tokyo Dent Coll, 2014,55(2):87-94. DOI: 10.2209/tdcpublication.55.87. pmid:24965953
[19]	East JE, Vleugels JL, Roelandt P, et al. Advanced endoscopic imaging: European Society of Gastrointestinal Endoscopy (ESGE) technology review[J]. Endoscopy, 2016,48(11):1029-1045. DOI: 10.1055/s-0042-118087. pmid:27711949
[20]	Oyama T, Inoue H, Arima M, et al. Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: magnifying endoscopic classification of the Japan Esophageal Society[J]. Esophagus, 2017,14(2):105-112. DOI: 10.1007/s10388-016-0527-7. doi:10.1007/s10388-016-0527-7pmid:28386209
[21]	Mizumoto T, Hiyama T, Quach DT, et al. Magnifying endoscopy with narrow band imaging in estimating the invasion depth of superficial esophageal squamous cell carcinomas[J]. Digestion, 2018,98(4):249-256. DOI: 10.1159/000489490.
[22]	Su Z, Wang L, Wei S, et al. Clinical diagnostic value of digestive endoscopic narrow-band imaging in early esophageal cancer[J]. Oncol Lett, 2019,17(6):5481-5486. DOI: 10.3892/ol.2019.10278. pmid:31186767
[23]	Ide E, Carneiro FO, Frazão MS. Endoscopic detection of early esophageal squamous cell carcinoma in patients with achalasia: narrow-band imaging versus Lugol's staining [J]. J Oncol, 2013,2013:736756. DOI: 10.1155/2013/736756. pmid:23935622
[24]	Wang P, Xiao X, Glissen Brown JR, et al. Development and validation of a deep-learning algorithm for the detection of polyps during colonoscopy[J]. Nat Biomed Eng, 2018,2(10):741-748. DOI: 10.1038/s41551-018-0301-3. pmid:31015647
[25]	Hirasawa T, Aoyama K, Tanimoto T, et al. Application of artificial intelligence using a convolutional neural network for detecting gastric cancer in endoscopic images[J]. Gastric cancer, 2018,21(4):653-660. DOI: 10.1007/s10120-018-0793-2. doi:10.1007/s10120-018-0793-2pmid:29335825
[26]	Nakashima H, Kawahira H, Kawachi H, et al. Artificial intelligence diagnosis of Helicobacter pylori infection using blue laser imaging-bright and linked color imaging: a single-center prospective study[J]. Ann Gastroenterol, 2018,31(4):462-468. DOI: 10.20524/aog.2018.0269. pmid:29991891
[27]	Horie Y, Yoshio T, Aoyama K, et al. Diagnostic outcomes of eso-phageal cancer by artificial intelligence using convolutional neural networks[J]. Gastrointest Endosc, 2019,89(1):25-32. DOI: 10.1016/j.gie.2018.07.037. doi:10.1016/j.gie.2018.07.037pmid:30120958
[28]	Zhao YY, Xue DX, Wang YL, et al. Computer-assisted diagnosis of early esophageal squamous cell carcinoma using narrow-band imaging magnifying endoscopy[J]. Endoscopy, 2019,51(4):333-341. DOI: 10.1055/a-0756-8754. pmid:30469155
[29]	Guo L, Xiao X, Wu C, et al. Real-time automated diagnosis of precancerous lesions and early esophageal squamous cell carcinoma using a deep learning model (with videos)[J]. Gastrointest Endosc, 2020,91(1):41-51. DOI: 10.1016/j.gie.2019.08.018. pmid:31445040
[30]	He LJ, Xie C, Wang ZX, et al. Submucosal saline injection followed by endoscopic ultrasound versus endoscopic ultrasound only for distinguishing between T_1aand T_1besophageal cancer[J]. Clin Cancer Res, 2020,26(2):384-390. DOI: 10.1158/1078-0432.CCR-19-1722. doi:10.1158/1078-0432.CCR-19-1722pmid:31615934
[31]	Li JJ, Shan HB, Xu GL, et al. Submucosal saline solution injection combined with endosonography for distinguishing between stages T_1aand T_1bof early esophageal cancer[J]. Gastrointest Endosc, 2013,77(1):159-160. DOI: 10.1016/j.gie.2012.08.028. doi:10.1016/j.gie.2012.08.028pmid:23261111
[32]	Li JJ, Shan HB, Gu MF, et al. Endoscopic ultrasound combined with submucosal saline injection for differentiation of T_1aand T_1besophageal squamous cell carcinoma: a novel technique[J]. Endoscopy, 2013,45(8):667-670. DOI: 10.1055/s-0033-1344024. pmid:23807801
[33]	蔺军平, 李政, 尹泚, 等. 超声内镜在食管癌临床TN分期诊断中的应用价值[J]. 中华实用诊断与治疗杂志, 2019,33(10):1008-1010. DOI: 10.13507/j.issn.1674-3474.2019.10.020.
[34]	Zhang Y, He S, Dou L, et al. Esophageal cancer N staging study with endoscopic ultrasonography[J]. Oncol Lett, 2019,17(1):863-870. DOI: 10.3892/ol.2018.9716. doi:10.3892/ol.2018.9716pmid:30655840
[35]	Hulshoff JB, Mul VEM, de Boer HEM, et al. Impact of endoscopic ultrasonography on¹⁸F-FDG-PET/CT upfront towards patient specific esophageal cancer treatment [J]. Ann Surg Oncol, 2017,24(7):1828-1834. DOI: 10.1245/s10434-017-5835-1. doi:10.1245/s10434-017-5835-1pmid:28303427
[36]	Lee G, I H, Kim SJ, et al. Clinical implication of PET/MR imaging in preoperative esophageal cancer staging: comparison with PET/CT, endoscopic ultrasonography, and CT[J]. J Nucl Med, 2014,55(8):1242-1247. DOI: 10.2967/jnumed.114.138974. doi:10.2967/jnumed.114.138974pmid:24868109

Application of endoscopic ultrasonography in the diagnosis of early esophageal cancer

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References36

Related Articles15

Recommended Articles

Metrics

Comments

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331.
[3]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[4]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[5]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[6]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[7]	Chen Qi, Xu Chenyang, Wang Yin, Lei Dapeng.Current application status of hyperspectral imaging in the diagnosis and treatment of head and neck tumor[J]. Journal of International Oncology, 2024, 51(5): 298-302.
[8]	Wang Kun, Zhou Zhongxin, Zang Qiwei.Predictive value of serum TGF-β1 and VEGF levels in patients with non-small cell lung cancer after single-port thoracoscopic radical resection[J]. Journal of International Oncology, 2024, 51(4): 198-203.
[9]	Wan Fang, Yang Gang, Li Rui, Wan Qijing.Expression levels and clinical significance of serum miR-497 and miR-383 in patients with esophageal cancer[J]. Journal of International Oncology, 2024, 51(4): 204-209.
[10]	Yan Aiting, Wang Cuizhu, Liu Chungui, Lu Xiaomin.Clinical efficacy and safety of camrelizumab and sintilimab in the treatment of advanced non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(3): 137-142.
[11]	Zhang Lili, Tan Ru, Fang Xueli, Yang Yu, Sang Zheng, Li Baosheng.Imaging diagnosis， pathological upgrade， and imaging technology progress of ductal carcinomain situof the breast[J]. Journal of International Oncology, 2024, 51(3): 166-169.
[12]	Peng Qin, Cai Yuting, Wang Wei.Advances on KPNA2 in liver cancer[J]. Journal of International Oncology, 2024, 51(3): 181-185.
[13]	Jiang Xi, Wu Yongcun, Liang Yan, Chu Li, Duan Yingxin, Wang Lijun, Huo Junjie.Impact of pembrolizumab combined with chemotherapy on angiogenesis and circulating endothelial cells in patients with advanced non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(2): 89-94.
[14]	Jin Xudong, Chen Zhongjian, Mao Weimin.Research progress on the role of MTAP in malignant mesothelioma[J]. Journal of International Oncology, 2024, 51(2): 99-104.
[15]	Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients[J]. Journal of International Oncology, 2024, 51(1): 37-42.